Journal of Developmental Therapeutics aims to advance the field of therapeutic development by providing a premier platform for high-quality research and innovative studies. Our goal is to facilitate the discovery, development, and optimization of new therapeutic strategies and interventions. We are dedicated to fostering interdisciplinary collaboration and translating scientific breakthroughs into effective treatments that address unmet medical needs.

All the manuscripts published by Journal of Developmental Therapeutics undergo rapid, quality and quick  review processing by eminent editorial and review team maintaining high standards and ethics of publishing.

The scholarly content published online will be freely available to every reader anywhere in the world to read, download, copy, reuse and distribute, provided that the original work is properly cited.

Authors may submit their valuable work either via the online submission form or via email to the editor’s office at submissions@asterpublications.com

Scope

Journal of Developmental Therapeutics encompasses a broad range of topics related to the development of new therapeutics, including but not limited to:

Drug Discovery and Development: Research on novel drug candidates, target identification, high-throughput screening, and early-phase development.

Preclinical Studies: Investigations into the efficacy, safety, and pharmacokinetics of therapeutic agents in animal models and in vitro systems.

Clinical Trials: Reports on the design, implementation, and outcomes of clinical trials, including Phase I-IV studies, and innovative trial methodologies.

Pharmacology and Toxicology: Studies on the mechanisms of drug action, pharmacodynamics, pharmacokinetics, and potential toxicities.

Biologics and Biotechnology: Research on biologics, including monoclonal antibodies, gene therapies, and recombinant proteins, and their development processes.

Targeted and Personalized Medicine: Advances in developing therapeutics tailored to specific genetic, molecular, or clinical characteristics of individual patients or patient populations.

Drug Delivery Systems: Innovations in drug delivery technologies, including nanoparticles, controlled-release systems, and novel formulation strategies.

Regulatory and Policy Issues: Discussion of regulatory requirements, guidelines, and policy developments that impact the development and approval of new therapeutics.

Therapeutic Areas: Focused research on specific disease areas, including oncology, cardiovascular diseases, neurodegenerative disorders, infectious diseases, and rare diseases.

Emerging Therapies: Exploration of cutting-edge therapeutic approaches such as CRISPR-based therapies, regenerative medicine, and digital health interventions.

The journal welcomes original research articles, review papers, clinical reports, and technical notes that contribute to the progress of therapeutic development. We aim to provide a forum for the exchange of knowledge and innovations that drive forward the development of effective and safe therapeutic interventions.

Key Topics

• Causes of cancer progression
• Drug Discovery/Development
• Clinical translational research
• Pharmacology
• Molecular and cellular biology
• Molecular genetics
• Synthetic chemistry
• Biomedical engineering
• Structural biology and molecular modeling
• Diagnostic imaging
• Pathology
• Clinical investigations
• Immunotherapy
• Mechanisms of resistance
• Cancer treatment strategies

Journal of Developmental Therapeutics follows the Committee on Publication Ethics (COPE) Guidelines for issues of fraud, image manipulation, and duplicate publication.

Click here for information on Publications Ethics and Guidelines.